A Compston, 2002, Lancet, 359, 1221, 10.1016/S0140-6736(02)08220-X
CA Formica, 1997, sclerosis: effect of ambulatory status and glucocorticoid use. Calcif Tissue Int, 61, 129
RS Taylor, 1996, Physical Medicine and Rehabilitation, 1101
J Nieves, 1994, Neurology, 44, 1687, 10.1212/WNL.44.9.1687
F Cosman, 1998, Neurology, 51, 1661, 10.1212/WNL.51.6.1661
SR Schwid, 1996, Arch Neurol, 53, 753, 10.1001/archneur.1996.00550080071014
CM Poser, 1983, sclerosis: guidelines for research protocols. Ann Neurol, 13, 227, 10.1002/ana.410130302
JF Kurtzke, 1983, Neurology, 33, 1444, 10.1212/WNL.33.11.1444
AA Kucukdeveci, 2001, Clin Rehabil, 15, 311, 10.1191/026921501676877265
M Peacock, 1989, Clinical Disorders of Bone and Mineral Metabolism, 265
TL Clemens, 1989, Clinical Disorders of Bone and Mineral Metabolism, 273
G Demirel, 1998, Spinal Cord, 36, 822, 10.1038/sj.sc.3100704
F Biering-Sorenson, 1988, Paraplegia, 26, 293, 10.1038/sc.1988.44
S Goemaere, 1994, Osteoporos Int, 4, 138, 10.1007/BF01623058
Y Sato, 1999, cally hospitalized disabled stroke patients. Age Ageing, 28, 265
Y Sato, 1997, Neurology, 49, 1273, 10.1212/WNL.49.5.1273
K Lucas, 1995, Neurology, 45, S4, 10.1212/WNL.45.6_Suppl_6.S4
A Gur, 2002, Rheumatol Int, 22, 194, 10.1007/s00296-002-0223-x
MF Holick, 2003, deficiency: what a pain it is. Mayo Clin Proc, 78, 1457, 10.4065/78.12.1457
RD Simmons, 2004, Mult Scler, 10, 202, 10.1191/1352458504ms1006oa
Y Sato, 1999, Neurology, 53, 437, 10.1212/WNL.53.2.437-a
Y Sato, 2003, Neurology, 61, 338, 10.1212/01.WNL.0000078892.24356.90
M Birdane, 2004, tibia: an indicator of low bone mineral density. J Bone Miner Metab, 22, 456
